Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I rolling the dice, took profits on other stocks rigjt before they soared and left lots and lots of profits on the table. Not this time..it's go for broke! All or None! Lol
Agree! Need to spread the word on the bigger boards! BB's & MOMO's
Great Consolidation, Great Support... Shook the Weak Hands, Now is the Time to Hold Strong and Run this Thing Up to Pennyland.
PMRS, Rumored to be heading into the Medical MJ field for Michigan! PR Expected soon. Chart showing strong support at 23/24.
PMRS reinstatement + Medical Marijuana rumor update.
1) They recently changed their business description to what could be marijuana. SIC - Industry Classification 2833 - Medicinal and botanicals
source: www.otcmarkets.com/stock/PMRS/company-info
2) REINSTATEMENT
Lock in your shares at a much higher sell price and they can't borrow.
PMRS; Big Volume Pending MJ Announcement!
Trust me. Anyone who knows these stocks, knows it will retrace 90% of the time, consolidate, then run free
Don't let them scare u out of your shares!
Scared Money, Don't Make Money
Let it retrace, shake the weak hands...it needs to happen for it to make a big run! It's all part of the process.
Agreed! An MJ PR will knock this out of the 00's
BIG WHALES Coming after Lunch!
Big Shake! Hold Strong ! BIG MJ MOVE Coming Soon! Don't be Sorry!
If 34/35 holds.. Be on Watch for Another breakout run
PMRS, Setting Up Nice. Check it out if you havent yet.
Lock in your shares for .01! That way they can't be borrowed!
If you sell prior to the "possible" MJ announcement....?? Wow...I couldn't do it. Lol
"Short Squeeze" to the Pennies!
PMRS, Up 200+% Pending Medical MJ News Release, Reinstatement Confirmed.
PMRS ~ News Release Announcement Involving PMRS to Enter into the Medical MJ Sector Pending and Expected Soon
With this share structure, chart, and the possible MJ news!?!? Wow, hang on tight! It's gonna get crazy!
PMRS, PVEC, VMGI
Higher low's, great Support rising, Looking to Breakout! On Alert
Selling now would be crazy! They haven't even released the actual MJ PR, when that happens! It's straight up to Pennies!
PMRS; Next Big MJ Mover! PR yet to be released, still time.
PMRS reinstatement + Medical Marijuana rumor update.
1) They recently changed their business description to what could be marijuana. SIC - Industry Classification 2833 - Medicinal and botanicals
source: www.otcmarkets.com/stock/PMRS/company-info
2) REINSTATEMENT
PMRS up 130+%, possible 500%-1,000% gains in the near future
PMRS, Running on MJ Rumors, When the actual PR hits, it's gonna be Huge!
I was curious. Thought it was my internet...
VMGI; NEWS-Verde Media Group Inc. Launches The Marijuana POT-CAST With The Alan Berman Show
LOS ANGELES, March 10, 2014 /PRNewswire/ -- Verde Media Group Inc. (OTC: VMGI)
The Alan Berman Show and Verde Media Group officially launch the Marijuana Pot-Cast. The show will air weekly on Fridays. The broadcast will feature industry professionals, comedians, actors, advocates, scientists and personalities that all have something to say about marijuana.
William Veve, President of Verde Media Group, Inc. stated, "This is a perfect way to educate and entertain an audience and keep current with a fast evolving industry while having a few laughs."
BIEL, JUST OUT!
BioElectronics Wins High Commendation In "Most Innovative New OTC Product Award" From OTC Bulletin
In Addition, Company Also Wins Runner-Up In Best Packaging Award For New ActiPatch? Therapy Box
FREDERICK, Md., March 7, 2014 /PRNewswire via COMTEX/ -- BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices won citations in two award categories from the OTC Bulletin, the leading global trade publication for over-the-counter healthcare products. The Smart Insole(TM) Heel Pain Therapy product was highly commended as the "Most Innovative New OTC Product Award" and the ActiPatch? Musculoskeletal Therapy was runner-up for its "Best New OTC Packaging Design Award."
While making its commendation in the Most Innovative New OTC Product category the award judges said, "BioElectronics' Smart Insole rides the wave of wearable tech' that looks likely to crash into the consumer healthcare market. It offers an innovative way to deal with an unglamorous and difficult-to-treat problem." Bayer AG was top entrant in the category with 35 points to BioElectronics' 32.
"This industry recognition caps a year of wins for our new Smart Insole(TM) Heel Pain Therapy product -- both in superb customer feedback and successful clinical trial results," said Andrew Whelan, president of BioElectronics Corporation. "Our customers have said that the Smart Insole product is the most successful, easy to use and proven treatment for common heel pain such as plantar fasciitis."
BioElectronics retail box for Boots, designed by its own in-house marketing team was named Runner-up in the "Best New OTC Packaging Design" finishing one point behind the winner, the Bray Lenino, ad agency. Judges said, "The ActiPatch brand provides a striking and distinctive design to help differentiate this new and alternative product in a sector that is already dominated by other leading brands."
The OTC Bulletin is firmly established as the most comprehensive and frequent source of news, views and analysis for pharmaceutical executives in the world's leading consumer healthcare companies in over 45 countries. A panel of independent experts experienced and knowledgeable in the OTC market judges each award.
BIEL NEWS JUST NOWBioElectronics Wins High Commendation In "Most Innovative New OTC Product Award" From OTC Bulletin
In Addition, Company Also Wins Runner-Up In Best Packaging Award For New ActiPatch? Therapy Box
FREDERICK, Md., March 7, 2014 /PRNewswire via COMTEX/ -- BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices won citations in two award categories from the OTC Bulletin, the leading global trade publication for over-the-counter healthcare products. The Smart Insole(TM) Heel Pain Therapy product was highly commended as the "Most Innovative New OTC Product Award" and the ActiPatch? Musculoskeletal Therapy was runner-up for its "Best New OTC Packaging Design Award."
While making its commendation in the Most Innovative New OTC Product category the award judges said, "BioElectronics' Smart Insole rides the wave of wearable tech' that looks likely to crash into the consumer healthcare market. It offers an innovative way to deal with an unglamorous and difficult-to-treat problem." Bayer AG was top entrant in the category with 35 points to BioElectronics' 32.
"This industry recognition caps a year of wins for our new Smart Insole(TM) Heel Pain Therapy product -- both in superb customer feedback and successful clinical trial results," said Andrew Whelan, president of BioElectronics Corporation. "Our customers have said that the Smart Insole product is the most successful, easy to use and proven treatment for common heel pain such as plantar fasciitis."
BioElectronics retail box for Boots, designed by its own in-house marketing team was named Runner-up in the "Best New OTC Packaging Design" finishing one point behind the winner, the Bray Lenino, ad agency. Judges said, "The ActiPatch brand provides a striking and distinctive design to help differentiate this new and alternative product in a sector that is already dominated by other leading brands."
The OTC Bulletin is firmly established as the most comprehensive and frequent source of news, views and analysis for pharmaceutical executives in the world's leading consumer healthcare companies in over 45 countries. A panel of independent experts experienced and knowledgeable in the OTC market judges each award.
BioElectronics Wins High Commendation In "Most Innovative New OTC Product Award" From OTC Bulletin
In Addition, Company Also Wins Runner-Up In Best Packaging Award For New ActiPatch? Therapy Box
FREDERICK, Md., March 7, 2014 /PRNewswire via COMTEX/ -- BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices won citations in two award categories from the OTC Bulletin, the leading global trade publication for over-the-counter healthcare products. The Smart Insole(TM) Heel Pain Therapy product was highly commended as the "Most Innovative New OTC Product Award" and the ActiPatch? Musculoskeletal Therapy was runner-up for its "Best New OTC Packaging Design Award."
While making its commendation in the Most Innovative New OTC Product category the award judges said, "BioElectronics' Smart Insole rides the wave of wearable tech' that looks likely to crash into the consumer healthcare market. It offers an innovative way to deal with an unglamorous and difficult-to-treat problem." Bayer AG was top entrant in the category with 35 points to BioElectronics' 32.
"This industry recognition caps a year of wins for our new Smart Insole(TM) Heel Pain Therapy product -- both in superb customer feedback and successful clinical trial results," said Andrew Whelan, president of BioElectronics Corporation. "Our customers have said that the Smart Insole product is the most successful, easy to use and proven treatment for common heel pain such as plantar fasciitis."
BioElectronics retail box for Boots, designed by its own in-house marketing team was named Runner-up in the "Best New OTC Packaging Design" finishing one point behind the winner, the Bray Lenino, ad agency. Judges said, "The ActiPatch brand provides a striking and distinctive design to help differentiate this new and alternative product in a sector that is already dominated by other leading brands."
The OTC Bulletin is firmly established as the most comprehensive and frequent source of news, views and analysis for pharmaceutical executives in the world's leading consumer healthcare companies in over 45 countries. A panel of independent experts experienced and knowledgeable in the OTC market judges each award.
BIEL; NEWS BioElectronics Wins High Commendation In "Most Innovative New OTC Product Award" From OTC Bulletin
In Addition, Company Also Wins Runner-Up In Best Packaging Award For New ActiPatch? Therapy Box
FREDERICK, Md., March 7, 2014 /PRNewswire via COMTEX/ -- BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices won citations in two award categories from the OTC Bulletin, the leading global trade publication for over-the-counter healthcare products. The Smart Insole(TM) Heel Pain Therapy product was highly commended as the "Most Innovative New OTC Product Award" and the ActiPatch? Musculoskeletal Therapy was runner-up for its "Best New OTC Packaging Design Award."
While making its commendation in the Most Innovative New OTC Product category the award judges said, "BioElectronics' Smart Insole rides the wave of wearable tech' that looks likely to crash into the consumer healthcare market. It offers an innovative way to deal with an unglamorous and difficult-to-treat problem." Bayer AG was top entrant in the category with 35 points to BioElectronics' 32.
"This industry recognition caps a year of wins for our new Smart Insole(TM) Heel Pain Therapy product -- both in superb customer feedback and successful clinical trial results," said Andrew Whelan, president of BioElectronics Corporation. "Our customers have said that the Smart Insole product is the most successful, easy to use and proven treatment for common heel pain such as plantar fasciitis."
BioElectronics retail box for Boots, designed by its own in-house marketing team was named Runner-up in the "Best New OTC Packaging Design" finishing one point behind the winner, the Bray Lenino, ad agency. Judges said, "The ActiPatch brand provides a striking and distinctive design to help differentiate this new and alternative product in a sector that is already dominated by other leading brands."
The OTC Bulletin is firmly established as the most comprehensive and frequent source of news, views and analysis for pharmaceutical executives in the world's leading consumer healthcare companies in over 45 countries. A panel of independent experts experienced and knowledgeable in the OTC market judges each award.
DSCR, Dip & Load! NEWS
$DSCR; MJ vapor pen acquisition
DSCR NEWS, MEDICAL EPENS
DSCR, NEWS: Discovery Minerals Ltd. Provides Additional Information on Letter of Intent With VPR Group, Inc.
RENO, NV, Mar 06, 2014 (eTeligis.com via COMTEX) Discovery Minerals Ltd. (OTC Pink: DSCR), The Company, has received many inquiries regarding further details on the VPR Group and appreciates all of this interest. We are conducting thorough due diligence and more information will be released as soon as the company is able. However we would like to provide some insight into what the acquisition of the VPR Group will entail and further details will follow once the acquisition is completed.
VPR Group, Inc. is a private label distributor of the VPR brand E-Pen/E-Cigs for medical purposes through its existing network of licensed Medical Marijuana Dispensaries.In addition, VPR Group, Inc. distributes a number of proprietary cannabis oil vapors and refill oil/vapor cartridges.These cannabis oil vapors are characterized into two categories: THC molecule only and CBD molecule only oils. In addition, VPR is actively pursuing further multiple uses of their proprietary cannabis oils to include but not limited to Edibles, Concentrates and Beverages.
VPR Group, Inc. management is positioning the company to be recognizedas apremier distributor in the rapidly expanding Medical Marijuana industry by developing designer style oil strands to address specific medical needs. As we scale our growth into all current and future states with favorable Medical Marijuana laws, management will drive the corporate culture to emphasize high quality products and service.
About Discovery Minerals Ltd .Discovery Minerals Ltd., (OTC Pink: DSCR) is a production stage company formed to acquire and develop natural resource properties. Activities include gold, precious metals and petroleum minerals, including rare earth minerals production and sales. The Company initiated a new program to evaluate undervalued assets, including clean tech and alternative energy investments, for potential addition to its portfolio.
Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.
Contact Person :Henry ManayanAt: info@discoveryminerals.com
Report TOS
NEWS: Discovery Minerals Ltd. Provides Additional Information on Letter of Intent With VPR Group, Inc.
RENO, NV, Mar 06, 2014 (eTeligis.com via COMTEX) Discovery Minerals Ltd. (OTC Pink: DSCR), The Company, has received many inquiries regarding further details on the VPR Group and appreciates all of this interest. We are conducting thorough due diligence and more information will be released as soon as the company is able. However we would like to provide some insight into what the acquisition of the VPR Group will entail and further details will follow once the acquisition is completed.
VPR Group, Inc. is a private label distributor of the VPR brand E-Pen/E-Cigs for medical purposes through its existing network of licensed Medical Marijuana Dispensaries.In addition, VPR Group, Inc. distributes a number of proprietary cannabis oil vapors and refill oil/vapor cartridges.These cannabis oil vapors are characterized into two categories: THC molecule only and CBD molecule only oils. In addition, VPR is actively pursuing further multiple uses of their proprietary cannabis oils to include but not limited to Edibles, Concentrates and Beverages.
VPR Group, Inc. management is positioning the company to be recognizedas apremier distributor in the rapidly expanding Medical Marijuana industry by developing designer style oil strands to address specific medical needs. As we scale our growth into all current and future states with favorable Medical Marijuana laws, management will drive the corporate culture to emphasize high quality products and service.
About Discovery Minerals Ltd .Discovery Minerals Ltd., (OTC Pink: DSCR) is a production stage company formed to acquire and develop natural resource properties. Activities include gold, precious metals and petroleum minerals, including rare earth minerals production and sales. The Company initiated a new program to evaluate undervalued assets, including clean tech and alternative energy investments, for potential addition to its portfolio.
Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.
Contact Person :Henry ManayanAt: info@discoveryminerals.com
Report TOS